These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2659055)

  • 41. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 42. [Liver cirrhosis: pathogenesis of ascites and disturbance of renal function].
    Toledo C; Ginés P; Arroyo V
    Rev Med Chil; 1992 Feb; 120(2):180-7. PubMed ID: 1340557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Surgical treatment of ascites in cirrhosis of the liver].
    Shalimov AA; Kalita NIa; Kotenko OG; Bulakov KI
    Khirurgiia (Mosk); 1990 Jan; (1):38-41. PubMed ID: 2329741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Janssens AR; van Brummelen P
    Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1156-9. PubMed ID: 7402394
    [No Abstract]   [Full Text] [Related]  

  • 46. Pathogenesis of ascites in cirrhosis.
    Arroyo V; Badalamenti S; Ginès P
    Minerva Med; 1987 May; 78(10):645-50. PubMed ID: 3587709
    [No Abstract]   [Full Text] [Related]  

  • 47. Physiologic considerations in the medical management of ascites.
    Frakes JT
    Arch Intern Med; 1980 May; 140(5):620-3. PubMed ID: 7396587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology to practice.
    Grangé JD; Amiot X
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):567-70. PubMed ID: 15167158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravascular volume in cirrhosis. Reassessment using improved methodology.
    Rector WG; Ibarra F
    Dig Dis Sci; 1988 Apr; 33(4):460-6. PubMed ID: 3349893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
    Ackermann D
    Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of refractory ascites].
    Martínez J; Albillos A
    Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():68-73. PubMed ID: 25087715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyponatremia in cirrhosis: pathophysiology and management.
    John S; Thuluvath PJ
    World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cirrhotic ascites. Pathophysiology, diagnosis, and management.
    Rocco VK; Ware AJ
    Ann Intern Med; 1986 Oct; 105(4):573-85. PubMed ID: 2944463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
    Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D
    Nephron; 1993; 65(3):359-63. PubMed ID: 8289984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites.
    Solà E; Sanchez-Cabús S; Rodriguez E; Elia C; Cela R; Moreira R; Pose E; Sánchez-Delgado J; Cañete N; Morales-Ruiz M; Campos F; Balust J; Guevara M; García-Valdecasas JC; Ginès P
    Liver Transpl; 2017 May; 23(5):583-593. PubMed ID: 28318147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraperitoneal pressure: ascitic fluid and splanchnic vascular pressures, and their role in prevention and formation of ascites.
    Henriksen JH; Stage JG; Schlichting P; Winkler K
    Scand J Clin Lab Invest; 1980 Oct; 40(6):493-501. PubMed ID: 7444353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of sodium and water retention in liver disease.
    Niederberger M; Schrier RW
    Prog Liver Dis; 1992; 10():329-47. PubMed ID: 1296235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.